Verition Fund Management LLC Karuna Therapeutics, Inc. Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $1.67 Million - $3.3 Million	10,377 Added 453.54%	12,665 $4.01 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $549,635 - $727,951	-3,338 Reduced 59.33%	2,288 $386,000
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $991,976 - $1.35 Million	5,626 New	5,626 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $37,539 - $46,416	196 Added 9.79%	2,199 $432,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $51,249 - $114,851	414 Added 26.05%	2,003 $451,000
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $149,318 - $227,751	1,589 New	1,589 $201,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.